Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses

Journal of Pathology

Volumn 199, Issue 1, 2003, Pages 50-57

  Obermann, E C ^a   Junker, K ^b   Stoehr, R ^a   Dietmaier, W ^a   Zaak, D ^c   Schubert, J ^b   Hofstaedter, F ^a   Knuechel, R ^a   Hartmann, A ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Bladder cancer; CGH; Chromosome 9; FISH; Flat urothelial hyperplasia; LOH; Papillary tumour

Indexed keywords

AMINOLEVULINIC ACID; MICROSATELLITE DNA;

ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER INVASION; CHROMOSOME 11Q; CHROMOSOME 12Q; CHROMOSOME 17P; CHROMOSOME 2Q; CHROMOSOME 9P; CHROMOSOME 9Q; CHROMOSOME DELETION; CHROMOSOME LOSS; CHROMOSOME MICRODISSECTION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DETERMINATION; EARLY CANCER; EPITHELIUM HYPERPLASIA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROSATELLITE MARKER; MOLECULAR CLONING; PRIORITY JOURNAL; UROTHELIUM;

AGED; CARCINOMA, PAPILLARY; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; GENOME, HUMAN; HUMANS; HYPERPLASIA; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NUCLEIC ACID HYBRIDIZATION; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0037222796     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1259     Document Type: Article

References (42)

1. Mostofi FK, Davis CJJ, Sesterhenn IA. Histological typing of urinary bladder tumours. In World Health Organization - International Histological Classification of Tumours. Mosteti FW, Davis CJ, Sesterhenn IA (eds). Springer: Berlin, 1999; 20.
2. Koss LG, Tiamson EM, Robbins MA. Mapping cancerous and precancerous bladder changes. A study of the urothelium in ten surgically removed bladders. J Am Med Assoc 1974; 227: 281-286.
3. Sarma KP. Genesis of papillary tumours: histological and microangiographic study. Br J Urol 198 1; 53: 228-236.
4. Cordon-Cardo C, Cote RJ, Sauter G. Genetic and molecular markers of urothelial premalignancy and malignancy. Scand J Urol Nephrol 2000; 205: 82-93.
5. Fearon ER, Vogelstein B. A genetic model for colorectal tumourigenesis. Cell 1990; 61: 759-767.
6. Czerniak B, Li L, Chaturvedi V, et al. Genetic modeling of human urinary bladder carcinogenesis. Genes Chromosomes Cancer 2000; 27: 392-402.
7. Spruck CH, Ohneseit PF, Gonzalez-Zulueta M, et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 1994; 54: 784-788.
8. Hartmann A, Moser K, Kriegmair M, Hofstetter A, Hofstaedter F, Knuechel R. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. Am J Pathol 1999; 154: 721-727.
9. Hartmann A, Schlake G, Zaak D, et al. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder. Cancer Res 2002; 62: 809- 818.
10. Cheng L, Cheville JC, Neumann RM, Bostwick DG. Flat intraepithelial lesions of the urinary bladder. Cancer 2000; 88: 625-631.
11. Chow NH, Cairns P, Eisenberger CF, et al. Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer. Int J Cancer 2000; 89: 514-518.
12. Kriegmair M, Baumgartner R, Knuchel R, Stepp H, Hofstadter F, Hofstetter A. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 1996; 155: 105-109.
13. Hartmann A, Rosner U, Schlake G, et al. Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis. Lab Invest 2000; 80: 709-718.
14. Stoehr R, Hartmann A, Hiendlmeyer E, Murle K, Wieland W, Knuechel R. Oligoclonality of early lesions of the urothelium as determined by microdissection-supported genetic analysis. Pathobiology 2000; 68: 165-172.
15. Wild P, Knuechel R, Dietmaier W, Hofstaedter F, Hartmann A. Laser microdissection and microsatellite analyses of breast cancer reveal a high degree of tumour heterogeneity. Pathobiology 2000; 68: 180-190.
16. Dietmaier W, Hartmann A, Wallinger S, et al. Multiple mutation analyses in single tumour cells with improved whole genome amplification. Am J Pathol 1999; 154: 83-95.
17. Kriegmair M, Baumgartner R, Knuechel R, et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 1994; 44: 836-841.
18. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours. New York, Wiley-Liss: Weinheim 1997.
19. Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA, Tunnacliffe A. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 1992; 13: 718-725.
20. Chudoba I, Senger G, Haas O. Comparative genomic hybridisation using DOP-PCR amplified DNA from a small number of nuclei. Cs Pediatr 1997; 52: 519-521.
21. Cairns P, Polascik TJ, Eby Y, et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nature Genet 1995; 11: 210-212.
22. Taylor DC, Bhagavan BS, Larsen MP, Cox JA, Epstein JI. Papillary urothelial hyperplasia. A precursor to papillary neoplasms. Am J Surg Pathol 1996; 20: 1481-1488.
23. Bryan GT. The pathogenesis of experimental bladder cancer. Cancer Res 1977; 37: 2813-2816.
24. Jacobs JB, Arai M, Cohen SM, Friedell GH. A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Cancer Res 1977; 37: 2817-2821.
25. Cohen SM, Jacobs JB, Arai M, Johansson S, Friedell GH. Early lesions in experimental bladder cancer: experimental design and light microscopic findings. Cancer Res 1976; 36: 2508-2511.
26. Ruppert JM, Tokino K, Sidransky D. Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer 1993; 53: 5093-5095.
27. Miyao N, Tsai YC, Lerner SP, et al. Role of chromosome 9 in human bladder cancer. Cancer Res 1993; 53: 4066-4070.
28. Sauter G, Moch H, Carroll P, Kerschmann R, Mihatsch MJ, Waldman FM. Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer. Int J Cancer 1995; 64: 99-103.
29. Simoneau AR, Spruck CH, Gonzalez-Zulueta M, et al. Evidence for two tumour suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. Cancer Res 1996; 56: 5039-5043.
30. Simoneau M, Aboulkassim TO, LaRue H, Rousseau F, Fradet Y. Four tumour suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31. Oncogene 1999; 18: 157-163.
31. Czerniak B, Chaturvedi V, Li L, et al. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer. Oncogene 1999; 18: 1185-1196.
32. Simon R, Eltze E, Schafer KL, et al. Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumour cells. Cancer Res 2001; 61: 355-362.
33. Kallioniemi A, Kallioniemi OP, Citro G, et al. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer 1995; 12: 213-219.
34. Voorter C, Joos S, Bringuier PP, et al. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Am J Pathol 1995; 146: 1341-1354.
35. Richter J, Beffa L, Wagner U, et al. Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am J Pathol 1998; 153: 1615-1621.
36. Simon R, Burger H, Semjonow A, Hertle L, Terpe HJ, Bocker W. Patterns of chromosomal imbalances in muscle invasive bladder cancer. Int J Oncol 2000; 17: 1025-1029.
37. Prat E, Bernues M, Caballin MR, Egozcue J, Gelabert A, Miro R. Detection of chromosomal imbalances in papillary bladder tumours by comparative genomic hybridization. Urology 2001; 57: 986-992.
38. Richter J, Jiang F, Gorog JP, et al. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 1997; 57: 2860-2864.
39. Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B. Clonal origin bladder cancer. N Engl J Med 1992; 326: 737-740.
40. Hafner C, Knuechel R, Zanardo L, et al. Evidence for oligoclonality and tumour spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tract. Oncogene 2001; 20: 4910-4915.
41. Takahashi T, Kakehi Y, Mitsumori K, et al. Distinct microsatellite alterations in upper urinary tract tumours and subsequent bladder tumours. J Urol 2001; 165: 672-677.
42. Paiss T, Wohr G, Hautmann RE, et al. Some tumours of the bladder are polyclonal in origin. J Urol 2002; 167: 718-723.